5805-89-0

Upstream product

• 1204-29-1 1-ethyl-2,4-dinitrobenzene 
• 3663-34-1 N-(4-ethylphenyl)acetamide 
• 589-16-2 4-aminoethylbenzene 
• 51529-96-5 4-ethyl-3-nitroaniline 
• 108-24-7 acetic anhydride 

Downstream Products

• 51529-96-5 4-ethyl-3-nitroaniline 
• 3843-97-8 2-ethyl-5-chloroaniline 
• 2001-16-3 4-chloro-1-ethyl-2-nitrobenzene 
• 335201-54-2 4-ethyl-2,3-dinitrobenzeneamine 
• 15147-64-5 2,3-di-nitrobenzoic acid 
• 610-28-6 2,5-dinitrobenzoic acid 
• 335201-63-3 C₁₀H₉ClN₂O₆ 
• 335201-59-7 2-(2,5-dinitrophenyl)propan-1-ol 
• 13985-58-5 2-ethyl-1,4-dinitrobenzene 
• 702642-07-7 1-bromo-3-ethyl-2-nitrobenzene 
• 702642-03-3 3-ethyl-2-nitrobenzeneamine 
• 335201-55-3 4-ethyl-2,5-dinitrobenzeneamine 
• 392303-95-6 acetic acid-(4-ethyl-2,3-dinitro-anilide) 

Relevant academic research and scientific papers

PYRAZOLO[1,5a]PYRIMIDINE DERIVATIVES AS IRAK4 MODULATORS

Compounds of the formula I or II: wherein X, m, Ar, R1 and R2 are as defined herein. The subject compounds are useful for treatment of IRAK-mediated conditions.

Nucleoside derivatives with photolabile protective groups

The invention relates to nucleoside derivatives with photolabile protecting groups of general formula (I), where R1=H, F, Cl, Br, I, NO2; R2=H, CN, where R1 and R2 are not simultaneously H; R3=H, 1-4 C alkyl, phenyl; R4=H or a conventional functional group for the synthesis of oligonucleotides; R5=H, OH, halogen or XR6, where X=O or S and R6=a conventional nucleotide protecting group; B=adenine, cytosine, guanine, thymine, uracil, 2,6-diaminopurin-9-yl, hypoxanthin-9-yl, 5-methylcytosin-1-yl, 5-amino-4-imidazolcarboxamid-1-yl or 5-amino-4-imidazolcarboxamid-3-yl, where, if B=adenine, cytosine or guanine the primary amine functionality, optionally, carries a permanent protecting group. Furthermore, these derivatives may be used for the light-controlled synthesis of oligonucleotides on a DNA chip.